1093396-29-2

Upstream product

• 1093395-66-4 4-(5-cyano-7-isopropyl-benzooxazol-2-yl)-benzoic acid 
• 1093396-30-5 ({4-phenyl-1-[5-(trifluoromethyl)pyridin-2-yl]piperidin-4-yl}methyl)amine 
• 1093395-68-6 methyl 4-(5-cyano-7-isopropyl-1,3-benzoxazol-2-yl)benzoate 
• 1093395-67-5 methyl 4-(5-cyano-7-isopropenyl-1,3-benzoxazol-2-yl)benzoate 
• 1093395-65-3 methyl 4-(7-bromo-5-cyano-1,3-benzoxazol-2-yl)benzoate 
• 862730-24-3 3-amino-5-bromo-4-hydroxybenzonitrile 
• 1828-58-6 3-bromo-4-hydroxy-5-nitrobenzonitrile 
• 1689-84-5 Bromoxynil 

Relevant academic research and scientific papers

CETP INHIBITORS DERIVED FROM BENZOXAZOLE ARYLAMIDES

Compounds having the structure of Formula I1 including pharmaceutically acceptable salts of the compounds, are potent CETP (cholesterol ester transfer protein) inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis Atherosclerosis and its clinical consequences, coronary heart disease (CHD), stroke and penpheral vascular disease, represent a truly enormous burden to the health care systems ofthe industrialized world In formula I, A-B is an arylamide moiety